BJDX CIK: 1704287

Bluejay Diagnostics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
20.7
FY22:
11.8
FY23:
3.22
FY24:
4.90
FY25:
5.46
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.36
FY22:
1.73
FY23:
1.65
FY24:
1.76
FY25:
1.66
Total assets
Change from FY21 to FY25
millions USD
FY21:
21.0
FY22:
13.5
FY23:
4.87
FY24:
6.66
FY25:
7.12

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
0.64
FY22:
1.64
FY23:
1.77
FY24:
0.81
FY25:
1.12
(negative)
millions USD
FY21:
0
FY22:
0.34
FY23:
0.20
FY24:
0.12
FY25:
0.02
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.4
FY22:
11.5
FY23:
2.89
FY24:
5.73
FY25:
5.98
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
21.0
FY22:
13.5
FY23:
4.87
FY24:
6.66
FY25:
7.12

All amounts in millions USD Data sources:SEC EDGARTwelve Data